跳至主要内容
临床试验/NCT04439643
NCT04439643已完成不适用

Plaque Stratification Using Ccta in Coronary ARtery Disease (PoSTCARD)

Elucid Bioimaging Inc.1 个研究点 分布在 1 个国家目标入组 800 人开始时间: 2020年2月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
800
试验地点
1
主要终点
Time to adverse outcome

研究概览

简要总结

Develop time-to-event prediction and plaque phenotype classification models for patients with known or suspected coronary artery disease.

详细描述

Develop time-to-event prediction and plaque phenotype classification models using plaque morphology and composition assessment of CTA which has been validated by histology, applied to representative cohort of patients. Generalizability of models is enhanced by using validated rather than only raw image inputs. Demographic, clinical, and outcome data is collected for enrolled patients as well as last known well dates.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject must have successfully completed at least one (possibly multiple) CCTA for known or suspected coronary artery disease, which was positive for coronary atherosclerotic changes.
  • Subject must have been ≥ 18 years of age at the time of the CCTA

排除标准

  • Subject has a history of percutaneous coronary intervention (PCI) with stent implantation and/or coronary artery bypass grafting (CABG)
  • CCTA taken less than 3 months after deployment of new scanner
  • Subject with insufficient CCTA image quality

结局指标

主要结局

Time to adverse outcome

时间窗: >= 2 years

Develop time-to-event model for major adverse cardiac events (MACE) prediction on large retrospective cohort (and enable a prospective collection subsequent to this study). Consistent with this primary endpoint is the evaluation of all imaging-derived data that has a bearing on the diagnosis and prognosis of the subject.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Plaque Stratification Using Ccta in Coronary ARtery... | 临床试验